144 related articles for article (PubMed ID: 31916037)
1. Mixed adenoneuroendocrine carcinoma with loss of HER2 positivity after trastuzumab-based chemotherapy for HER2-positive gastric cancer: a case report.
Nagata H; Tsujimoto H; Yaguchi Y; Kouzu K; Itazaki Y; Ishibashi Y; Tsuchiya S; Sugihara T; Ito N; Harada M; Nomura S; Utsumi Y; Shimazaki H; Kishi Y; Ueno H
Surg Case Rep; 2020 Jan; 6(1):5. PubMed ID: 31916037
[TBL] [Abstract][Full Text] [Related]
2. [Remarkable Response to Trastuzumab Observed in a Case of Gastric Cancer with HER2-Negative Conversion].
Horii N; Morioka D; Yamaguchi K; Sato Y
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1207-1209. PubMed ID: 27760939
[TBL] [Abstract][Full Text] [Related]
3. [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Kim Y; Hosoda Y; Nishino M; Okano M; Kawada J; Yamasaki M; Nagai K; Yasui M; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1635-7. PubMed ID: 26805121
[TBL] [Abstract][Full Text] [Related]
4. Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3).
Seo S; Ryu MH; Park YS; Ahn JY; Park Y; Park SR; Ryoo BY; Lee GH; Jung HY; Kang YK
Gastric Cancer; 2019 May; 22(3):527-535. PubMed ID: 30386954
[TBL] [Abstract][Full Text] [Related]
5. [A Case of HER2-Positive Advanced Gastric Cancer with Multiple Liver Metastases Effectively Treated with Trastuzumab, Capecitabine, and Cisplatin Combination Therapy].
Kuga Y; Kitamura S; Okanobu H; Sakimoto H; Nishida T
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1211-1214. PubMed ID: 27760940
[TBL] [Abstract][Full Text] [Related]
6. EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
Wagner AD; Grabsch HI; Mauer M; Marreaud S; Caballero C; Thuss-Patience P; Mueller L; Elme A; Moehler MH; Martens U; Kang YK; Rha SY; Cats A; Tokunaga M; Lordick F
BMC Cancer; 2019 May; 19(1):494. PubMed ID: 31126258
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after multidisciplinary treatments for HER2-positive advanced gastric cancer with multiple liver and lung metastases.
Yoshioka S; Takahashi N; Fujisaki M; Takeshita K; Takano Y; Yano F; Toya N; Eto K
Surg Case Rep; 2023 Aug; 9(1):139. PubMed ID: 37548808
[TBL] [Abstract][Full Text] [Related]
8. Durable response of human epidermal growth factor receptor-2-positive gastric adenosquamous carcinoma to trastuzumab-based chemotherapy.
Kadowaki S; Yatabe Y; Nitta S; Ito Y; Muro K
Case Rep Oncol; 2014 Jan; 7(1):210-6. PubMed ID: 24803897
[TBL] [Abstract][Full Text] [Related]
9. [A Case of Unresectable Advanced Gastric Cancer Resected by Conversion Surgery after Trastuzumab Combination Chemotherapy].
Hirai M; Hanyu T; Ichikawa H; Kano Y; Muneoka Y; Usui K; Ishikawa T; Ishikawa H; Miura K; Tajima Y; Nakano M; Takizawa K; Shimada Y; Sakata J; Wakai T
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1515-1517. PubMed ID: 36733120
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy.
Dong CX; Fu JF; Ye XY; Li XF; Zhong X; Yuan Y
World J Gastroenterol; 2014 Sep; 20(34):12355-8. PubMed ID: 25232273
[TBL] [Abstract][Full Text] [Related]
11. A case of advanced gastric cancer showing HER2 positivity after chemotherapy.
Hirose S; Moriwaki T; Yamaura M; Suganuma D; Tajima H; Sato M; Enami C; Yamada T; Yamamoto Y; Sakamoto N; Hyodo I
Int Cancer Conf J; 2020 Jul; 9(3):112-115. PubMed ID: 32582513
[TBL] [Abstract][Full Text] [Related]
12. Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: a case report.
Semrau S; Agaimy A; Pavel M; Lubgan D; Schmidt D; Cavallaro A; Golcher H; Grützmann R; Fietkau R
J Med Case Rep; 2019 Mar; 13(1):82. PubMed ID: 30902067
[TBL] [Abstract][Full Text] [Related]
13. Successful subtotal gastrectomy and hepatectomy for HER2-positive gastric cancer with liver metastasis after trastuzumab-based chemotherapy: a case report.
Hirase Y; Arigami T; Kawasaki Y; Matsushita D; Shimonosono M; Tsuruda Y; Sasaki K; Yamasaki Y; Hagihara T; Noma H; Higashi M; Kurahara H; Ohtsuka T
Surg Case Rep; 2024 Mar; 10(1):51. PubMed ID: 38438775
[TBL] [Abstract][Full Text] [Related]
14. Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
Ishimine Y; Goto A; Watanabe Y; Yajima H; Nakagaki S; Yabana T; Adachi T; Kondo Y; Kasai K
Case Rep Gastrointest Med; 2015; 2015():132030. PubMed ID: 25893119
[TBL] [Abstract][Full Text] [Related]
15. A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group Study.
Abali H; Yalcin S; Onal HC; Dane F; Oksuzoglu B; Ozdemir N; Mertsoylu H; Artac M; Camci C; Karabulut B; Basal FB; Budakoglu B; Sendur MAN; Goktas B; Ozdener F; Baygul A
Am J Clin Oncol; 2021 Jul; 44(7):301-307. PubMed ID: 33979100
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of stage IV gastric cancer treated by resection of the primary tumor after chemotherapy combined with trastuzumab].
Nakayama Y; Kawasaki H; Wajima N; Kimura A; Nakai M; Yonaiyama S; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2188-90. PubMed ID: 24394055
[TBL] [Abstract][Full Text] [Related]
17. Strategy for treatment of stage IV human epidermal growth factor 2-positive gastric cancer: a case report.
Sakaguchi M; Shimoike N; Akagawa S; Kanaya S
J Med Case Rep; 2019 Feb; 13(1):42. PubMed ID: 30791934
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival of HER2 positive gastric cancer patient with multiple liver metastases who obtained pathological complete response after systemic chemotherapy: A case report.
Sakaue M; Sugimura K; Masuzawa T; Takeno A; Katsuyama S; Shinnke G; Ikeshima R; Kawai K; Hiraki M; Katsura Y; Ohmura Y; Hata T; Takeda Y; Murata K
Int J Surg Case Rep; 2022 May; 94():107097. PubMed ID: 35468379
[TBL] [Abstract][Full Text] [Related]
19. [A Case of HER2-Positive Gastric Cancer with Multiple Liver Metastases Treated with Curative Conversion Therapy after Chemotherapy].
Kato Y; Natsuki S; Iimori N; Okuno T; Kametani N; Noda E; Yamamoto A; Yamada N; Nishimura S; Taenaka N; Matsunaga Y; Fujita S
Gan To Kagaku Ryoho; 2020 Apr; 47(4):682-684. PubMed ID: 32389983
[TBL] [Abstract][Full Text] [Related]
20. [Two Cases of HER2-Positive Gastric Cancer with Multiple Liver Metastases Leading to Conversion Therapy with Chemotherapy].
Ono HA; Kaneshiro M; Nakashima M; Baba H; Abe T; Kumagai J; Sugita M
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1662-1664. PubMed ID: 29394735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
